RT Journal Article
SR Electronic
T1 GWAS-based Machine Learning for Prediction of Age-Related Macular Degeneration Risk
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19006155
DO 10.1101/19006155
A1 Yan, Qi
A1 Jiang, Yale
A1 Huang, Heng
A1 Swaroop, Anand
A1 Chew, Emily Y.
A1 Weeks, Daniel E.
A1 Chen, Wei
A1 Ding, Ying
YR 2019
UL http://medrxiv.org/content/early/2019/09/16/19006155.abstract
AB Numerous independent susceptibility variants have been identified for Age-related macular degeneration (AMD) by genome-wide association studies (GWAS). Since advanced AMD is currently incurable, an accurate prediction of a person’s AMD risk using genetic information is desirable for early diagnosis and clinical management. In this study, genotype data of 32,215 Caucasian individuals with age above 50 years from the International AMD Genomics Consortium in dbGAP were used to establish and validate prediction models for AMD risk using four different machine learning approaches: neural network, lasso regression, support vector machine, and random forest. A standard logistic regression model was also considered using a genetic risk score. To identify feature SNPs for AMD prediction models, we selected the genome-wide significant SNPs from GWAS. All methods achieved good performance for predicting normal controls versus advanced AMD cases (AUC=0.81∼0.82 in a separate test dataset) and normal controls versus any AMD (AUC=0.78∼0.79). By applying the state-of-art machine learning approaches on the large AMD GWAS data, the predictive models we established can provide an accurate estimation of an individual’s AMD risk profile across the person’s lifespan based on a comprehensive genetic information.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableThe study subjects are from the International Age-Related Macular Degeneration Genomics Consortium - Exome Chip Experiment dbGaP data set (phs001039.v1.p1). https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001039.v1.p1